Literature DB >> 1236607

The role of the kidney in essential hypertension.

T G Coleman, A C Guyton, D B Young, J W DeClue, R A Norman, J Manning, R D Manning.   

Abstract

1. Many forms of human and experimental hypertension begin with compromised renal function. Essential hypertension may be another such case. 2. The kidneys of subjects with essential hypertension excrete normal amounts of salt and water at higher-than-normal renal perfusing pressures. Other overt signs of renal dysfunction are few; renal disease is excluded by definition. However, renal blood flow and glomerular filtration rate are usually less than normal in essential hypertension. 3. Renal afferent resistance can be calculated from arterial pressure, renal blood flow, and an estimate of glomerular capillary pressure. These calculations indicate that afferent resistance is increased to two or more times normal in essential hypertension. 4. It is not clear whether afferent constriction causes hypertension or results from it. The ability of high pressure to produce vascular damage points to the latter. But, most essential hypertensives show low-to-normal plasma renin levels and a marked afferent dilation after saline loading. These observations do not suggest nephrosclerosis: they are consistent with a causal role for afferent constriction. 5. We can speculate that, in essential hypertension, there is a defect in one of the mechanisms that sets afferent resistance. Afferent constriction could result from extrinsic influences (neural or humoral) or something totally within the kidney, such as abnormal handling of information from the macula densa. 6. The effect of afferent constriction on salt-and-water excretion would theoretically be offset by elevated arterial pressure so that the actual salt-and-water excretion would be normal, but only so long as the arterial pressure remained elevated.

Entities:  

Mesh:

Year:  1975        PMID: 1236607     DOI: 10.1111/j.1440-1681.1975.tb01862.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

1.  Sympathetic vascular tone in spontaneous hypertension of rats.

Authors:  A Schömig; R Dietz; W Rascher; J B Lüth; J F Mann; M Schmidt; J Weber
Journal:  Klin Wochenschr       Date:  1978

Review 2.  Should Renal Inflammation Be Targeted While Treating Hypertension?

Authors:  Sarika Chaudhari; Grace S Pham; Calvin D Brooks; Viet Q Dinh; Cassandra M Young-Stubbs; Caroline G Shimoura; Keisa W Mathis
Journal:  Front Physiol       Date:  2022-06-13       Impact factor: 4.755

3.  [Reduced urinary prostaglandin E2-excretion and diminished responsiveness of plasma renin activity in patients with essential hypertension (author's transl)].

Authors:  B Scherer; E Held; H H Lange; P C Weber
Journal:  Klin Wochenschr       Date:  1979-06-01

4.  Water handling by the sabra hypertension prone (SBH) and resistant (SBN) rats.

Authors:  Y Yagil; D Ben-Ishay; H Wald; M M Popovtzer
Journal:  Pflugers Arch       Date:  1985-05       Impact factor: 3.657

5.  Hypertension and arteriolar sclerosis of the kidney, pancreas, adrenal gland, and liver.

Authors:  R E Tracy; W D Johnson; C R Lopez; V T Toca
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

6.  Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.

Authors:  H J Kramer
Journal:  Klin Wochenschr       Date:  1981-11-16

Review 7.  The pathophysiology of hypertension in systemic lupus erythematosus.

Authors:  Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

Review 8.  How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure.

Authors:  Holly Digne-Malcolm; Matthew C Frise; Keith L Dorrington
Journal:  Front Physiol       Date:  2016-07-29       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.